Zobrazeno 1 - 10
of 612
pro vyhledávání: '"F. LUZZA"'
Autor:
E. Scarpellini, L. Abenavoli, V. Cassano, E. Rinninella, M. Sorge, F. Capretti, C. Rasetti, G. Svegliati Baroni, F. Luzza, P. Santori, A. Sciacqua
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
IntroductionGut microbiota are a complex ecosystem harboring our intestine. They maintain human body equilibrium, while their derangement, namely, “dysbiosis“, has been associated with several gastrointestinal diseases, such as liver steatosis (N
Externí odkaz:
https://doaj.org/article/d8573597d5b047288cc51010796b0893
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M.A. Latorre, P. Bianchi, M. Lenti, N. Aronico, C. Petrucci, C. D'Agate, M. Neri, U. Volta, M. Mumolo, M. Astegiano, A. Calabro, F. Zingone, G. Latella, A. Di Sario, A. Carroccio, C. Ciacci, F. Luzza, C. Bagnato, M. Fantini, L. Elli, G. Cammarota, A. Gasbarrini, P. Portincasa, C. Quatraccioni, C. Iannelli, N. Vecchione, G. Broglio, G. Ianiro, I. Marsilio, S. Bibbo, B. Marinoni, D. Tomaselli, L. Abenavoli, R. Pilia, G. Santacroce, E. Lynch, A. Carrieri, P. Mansueto, M. Gabba, G. Alunno, C. Rossi, F. Onnis, K. Efthymakis, N. Cesaro, M. Vernero, F. Baiano Svizzero, M. Silano, C. Klersy, G. Corazza, A. Di Sabatino
Publikováno v:
Digestive and Liver Disease. 55:S158-S159
Autor:
M. Maida, B. Annibale, A. Benedetti, P. Burra, L. Frulloni, G. Ianiro, F. Luzza, A. Repici, E. Savarino, E. Sinagra, M. Vecchi, L. Ricciardiello
Publikováno v:
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 54(10)
Colorectal cancer (CRC) is a major healthcare problem all over the world and screening is effective in reducing mortality and increasing survival. Since colonoscopy has a central role in faecal immunochemical test (FIT)-based CRC screening and survei
Autor:
T, Larussa, L, Abenavoli, A C, Procopio, C, Iannelli, N, Polimeni, R, Spagnuolo, P, Doldo, F, Luzza
Publikováno v:
European review for medical and pharmacological sciences. 25(21)
Celiac Disease (CD) is an autoimmune disease involving the small bowel, generated by the ingestion of gluten-containing foods in genetically predisposed subjects. Currently, the unique therapy for CD is the absolute adherence to gluten-free diet, but
Publikováno v:
European review for medical and pharmacological sciences. 25(18)
Non-Alcoholic Fatty Liver Disease (NAFLD), as a hepatic manifestation of metabolic syndrome (MET)-related obesity, insulin resistance, dyslipidemia, and hypertension, is the main cause of chronic liver disease. Inflammatory Bowel Diseases (IBD), (Cro
Autor:
T, Larussa, L, Abenavoli, A, Corea, A C, Procopio, L, Giubilei, R, Vallelunga, N, Polimeni, E, Suraci, R, Marasco, M, Imeneo, L, Boccuto, F, Luzza
Publikováno v:
European review for medical and pharmacological sciences. 25(10)
Diet, visceral sensitivity, and psychological distress play an important role in Irritable Bowel Syndrome (IBS). This study focused on the relation between IBS severity, foods, visceral sensitivity, and anxiety/depression.Patients with IBS were inves
Autor:
A, Tursi, G, Mocci, A, Cuomo, L, Allegretta, G, Aragona, R, Colucci, N, Della Valle, A, Ferronato, G, Forti, F, Gaiani, M G, Graziani, R, Lorenzetti, F, Luzza, P, Paese, A, Penna, R, Pica, S, Piergallini, G, Pranzo, S, Rodino, A, Scarcelli, C, Zampaletta, C, Cicerone, A, Cocco, G, De' Angelis, L, Donnarumma, M, Franceschi, S, Gallina, G, Grasso, T, Larussa, I, Luppino, R, Faggiani, L, Fanigliulo, C, Pagnini, P, Perazzo, R, Sacco, L, Sebkova, S, Scorza, M, Serio, A, De Monti, M, Picchio, W, Elisei, G, Maconi
Publikováno v:
European review for medical and pharmacological sciences. 25(4)
Ustekinumab (UST) is an anti-IL12/23 antibody for the treatment of Crohn's Disease (CD). The aim of this study was to compare the efficacy and safety of UST in a large population-based cohort of CD patients who failed previous treatment with other bi